North America Point of Care Diagnostics Market by Products (Glucose Testing, Hb1ac Testing, Coagulation, Fertility, Cardiac Makers, Infectious Diseases, Primary Acre Systems, Hematology, and Ambulatory Chemistry), End-users (Hospital, Home, Assisted Living Healthcare Facilities, Laboratory, Emergency Rooms, and Clinics), and Geography (the US and Canada) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The North America point of care diagnostics market size is attributed to the increasing awareness of home healthcare and cost-effective along with providing an effective and swift results offered by the point of care diagnostics. Moreover, the presence of a large number of health-conscious population in the region presents a major aspect for the market expansion.
Point of care (POC) testing refers to a testing method primarily designed to offer extreme convenience to patient treatment and care. These testing methods are distinguished from the normal ones since the former testing reduces the long procedures of sending report from laboratory to physicians handling the patient. Since the testing offers to reduce the overall time taken for the specimen’s result, it is widely used in many applications such as gas of blood & electrolytes analysis, rapid cardiac maker diagnostics, urine strips testing, fecal occult blood analysis, hemoglobin diagnostics, cholesterol screening, blood glucose testing, rapid coagulation testing, drugs of abuse screening, pregnancy testing, food pathogens screening, and infectious disease testing.
According to a survey conducted by World Health Organization (WHO), the number of adopting diagnostics devices and POC products for several diseases treatment is growing rapidly over the recent years in North America. Moreover, the outbreak of COVID-19 pandemic has impacted the regional market since the demand for Rapid Antigen Test (RAT) has been increased significantly. The rapid diagnostic test is widely used for the detection of SARS-CoV-2; the virus responsible for the COVID-19 pandemic. The successful testing of several RAT diagnostic devices in a global scale and consecutively in North America became an imperative for the expansion of POC diagnostics market.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing occurrences of infectious disease and chronic illness due to inactive lifestyle is projected to boost the market growth during the forecast period.
- Rapid development of innovative diagnostic products used for efficacy and automation are major factors driving the market expansion in the coming years.
- High cost of POCT devices and treatment and complex regulations regarding medical insurance are estimated to impede the market expansion.
- Lack of skilled labor handling the POC diagnostic devices present a main challenge that can restrict the market expansion in the coming years.
- R&D investment and technological advancement that can aid in the production of RAT and other diagnostic equipment are expected to offer significant opportunities for the market players.
Scope of the Report
The report on the North America point of care diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Point of Care Diagnostics Market – North America Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Products (Glucose Testing, Hb1ac Testing, Coagulation, Fertility, Cardiac Makers, Infectious Diseases, Primary Acre Systems, Hematology, and Ambulatory Chemistry) and End-users (Hospital, Home, Assisted Living Healthcare Facilities, Laboratory, Emergency Rooms, and Clinics) |
|
Geographical Scope |
The US and Canada |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Spectral Diagnostics; Abbott Laboratories; Nova Biomedical; Abaci’s Inc; Siemens Healthcare; Danaher Corporation; Instrumentation Laboratory; Trinity Biotech; Qiagen NV; BioMerieux; Johnson & Johnson; Roche Diagnostics; Alere Inc; Qualcomm Life Inc; and Nipro Diagnostics |
North America Point of Care Diagnostics Market Segment Insights
Glucose testing segment is projected to represent a large market share
Based on products, the North America point of care diagnostics market is segmented into glucose testing, Hb1ac testing, coagulation, fertility, cardiac makers, infectious diseases, primary acre systems, Hematology, and Ambulatory Chemistry . The glucose testing segment is expected to constitute a major share of the market during the forecast years. This segment dominance is mainly attributed due to the regular occurrences of obesity & diabetes, along with the presence of major players in the market offering innovative products in this segment. On the other hand, the Hb1ac testing segment is anticipated to grow at a rapid pace during the forecast period owing to the increasing presence of product portfolio and cost effectiveness to the huge patient base for obesity and diabetes management.
Clinics segment to constitute a major market share
On the basis of end-users, the market is divided into hospital, home, assisted living healthcare facilities, laboratory, emergency rooms, and clinics. The clinics segment is expected to constitute a major share of the market during the forecast years owing to the cumulative government regulations for more accurate tests in the fields of meta-analysis. Technological innovations present in the product lines, which enable precise & accurate diagnosis and effective monitoring of patients’ health conditions in clinics present key drivers for the segment growth. However, the home segment is expected to grow at a swift rate during the forecast period due to the rising usage of portable devices for health monitoring in home care settings.
US is anticipated to dominate the market
In terms of geography, the North America point of care diagnostics market is classified as the US and Canada. The US market held a major share of the global market revenue in 2020 and is expected to grow significantly during the forecast period. This regional market growth can be attributed to the presence of major global players based in the US. The market of Canada, however, is anticipating to account for a high growth rate during the forecast period due to the wide research and development activities, which are taking place in prominent research centres and universities.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point of Care Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point of Care Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point of Care Diagnostics Market - Supply Chain
4.5. Global Point of Care Diagnostics Market Forecast
4.5.1. Point of Care Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point of Care Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Point of Care Diagnostics Market Absolute $ Opportunity
5. Global Point of Care Diagnostics Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Point of Care Diagnostics Market Size and Volume Forecast by End Users
5.3.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Point of Care Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Point of Care Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Point of Care Diagnostics Demand Share Forecast, 2019-2026
7. North America Point of Care Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Point of Care Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Point of Care Diagnostics Market Size and Volume Forecast by End Users
7.4.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Point of Care Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Point of Care Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Point of Care Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Point of Care Diagnostics Market Size and Volume Forecast by End Users
8.4.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Point of Care Diagnostics Demand Share Forecast, 2019-2026
9. Europe Point of Care Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Point of Care Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Point of Care Diagnostics Market Size and Volume Forecast by End Users
9.4.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Point of Care Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Point of Care Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Point of Care Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Point of Care Diagnostics Market Size and Volume Forecast by End Users
10.4.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Point of Care Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Point of Care Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Point of Care Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Point of Care Diagnostics Market Size and Volume Forecast by End Users
11.4.1. Hospital Home Assisted Living Healthcare Facilities Laboratory Emergency Rooms
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Point of Care Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Point of Care Diagnostics Market: Market Share Analysis
12.2. Point of Care Diagnostics Distributors and Customers
12.3. Point of Care Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Spectral Diagnostics Abbott Laboratories Nova Biomedical Abaci’s Inc Siemens Healthcare
The North America point of care diagnostics market has been segmented in terms of
Products
- Glucose Testing
- Hb1ac Testing
- Coagulation
- Fertility
- Cardiac Makers
- Infectious Diseases
- Primary Acre Systems
- Hematology
- Ambulatory Chemistry
- Hospital
- Home
- Assisted Living Healthcare Facilities
- Laboratory
- Emergency Rooms
- Clinics
- The US
- Canada
- Spectral Diagnostics
- Abbott Laboratories
- Nova Biomedical
- Abaci’s Inc
- Siemens Healthcare
- Danaher Corporation
- Instrumentation Laboratory
- Trinity Biotech
- Qiagen NV
- BioMerieux
- Johnson & Johnson
- Roche Diagnostics
- Alere Inc
- Qualcomm Life Inc
- Nipro Diagnostics
Major players competing in the North America point of care diagnostics market are Spectral Diagnostics; Abbott Laboratories; Nova Biomedical; Abaci’s Inc; Siemens Healthcare; Danaher Corporation; Instrumentation Laboratory; Trinity Biotech; Qiagen NV; BioMerieux; Johnson & Johnson; Roche Diagnostics; Alere Inc; Qualcomm Life Inc; and Nipro Diagnostics. These players are also involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance, Qualcomm Inc. collaborated with Roche Diagnostics for several projects to develop techniques for effective patient monitoring solutions.
Our Clients
Related Reports
Some other reports from this category!
